Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (<scp>CRSwNP</scp>): A multicentric observational Phase IV real‐life study (<scp>DUPIREAL</scp>)

De Corso, Eugenio; Pasquini, Ernesto; Trimarchi, Matteo; La Mantia, Ignazio; Pagella, Fabio; Ottaviano, Giancarlo; Garzaro, Massimiliano; Pipolo, Carlotta; Torretta, Sara; Seccia, Veronica; Cantone, Elena; Ciofalo, Andrea; Lucidi, Daniela; Luca Fadda, Gian; Clara Pafundi, Pia; Settimi, Stefano; Montuori, Claudio; Anastasi, Francesca; Pagliuca, Giulio; Ghidini, Angelo; Cavaliere, Carlo; Maffei, Marianna; Bussu, Francesco; Gallo, Stefania; Rikki Canevari, Frank; Paludetti, Gaetano; Galli, Jacopo; Italian Study Group, Dupireal

doi:10.1111/all.15772

Public

Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real‐life study (DUPIREAL)

Published in Allergy • May 19, 2023

Authors:

Eugenio De Corso

Ernesto Pasquini

Matteo Trimarchi

Abstract

BACKGROUND: Chronic rhinosinusitis with nasal polyps (CRSwNP) is associated with significant morbidity and reduced health-related quality of life. Findings from clinical trials have demonstrated the effectiveness of dupilumab in CRSwNP, although real-world evidence is still limited. METHODS: This Ph...

Subject

Medicine

Dupilumab

Chronic rhinosinusitis

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!